Literature DB >> 15895180

[A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use].

Márcio Campos Oliveira1, Rivadávio Fernandes Batista de Amorim, Roseana de Almeida Freitas, Antonio de Lisboa Lopes Costa.   

Abstract

The authors report a case of mucocutaneous leishmaniasis in a 45-year-old patient who was unsuccessfully treated with pentavalent antimonial for 30 days. After 10 days from the initial treatment and before starting a new therapeutic regimen with the same drug the patient died due to sudden cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895180     DOI: 10.1590/s0037-86822005000300011

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

Review 1.  Liposomal drug delivery systems for the treatment of leishmaniasis.

Authors:  Felipe Francisco Tuon; Leticia Ramos Dantas; Regina Maia de Souza; Victoria Stadler Tasca Ribeiro; Valdir Sabbaga Amato
Journal:  Parasitol Res       Date:  2022-09-16       Impact factor: 2.383

2.  EVOLUTION OF AMERICAN TEGUMENTARY LEISHMANIASIS CASES REPORTED IN PARANÁ STATE, BRAZIL.

Authors:  Léia Regina de Souza Alcântara; Izabel Galhardo Demarchi; Sandra Mara Alessi Aristides
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

3.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

4.  Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.

Authors:  Rubén E Varela M; Diana Lorena Muñoz; Sara M Robledo; Bala K Kolli; Sujoy Dutta; Kwang Poo Chang; Carlos Muskus
Journal:  Exp Parasitol       Date:  2009-03-20       Impact factor: 2.011

5.  Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.

Authors:  Lindon Johoson Diniz Silveira; Thiago José Matos Rocha; Sandra Aparecida Ribeiro; Célia Maria Silva Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.